Contract Pharma

Breaking News | Collaborations & Alliances | Drug Discovery

Sartorius Expands AI Alliance with NVIDIA

Will combine Sartorius’ knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software.

05.16.24

Breaking News | Collaborations & Alliances

Syntegon Certified ‘PAS-X MSI Plug & Produce Ready’ by Körber

Ensures seamless and efficient integration of PAS-X MES with Syntegon's systems.

05.14.24

Bio News | Breaking News | Collaborations & Alliances | Drug Development

FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)

Aim to transform outcomes for patients with multiple types of cancer.

05.14.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Centogene and Evotec Discover New Potential Treatment for Gaucher Disease

Companies amend existing drug discovery partnership for Evotec to lead continued development.

05.14.24

Breaking News | Collaborations & Alliances | Drug Development | Industry News

Takeda, AC Immune Ink Exclusive Agreement for Alzheimer’s Immunotherapy

Worldwide option and license agreement includes AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060.

05.14.24

Breaking News | Collaborations & Alliances | Drug Discovery

NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery

Aim to create opportunities to target previously undruggable disease-causing proteins.

05.14.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP Encapsulation

Collaboration increases Aldevron’s services and capabilities as an mRNA sequence-to-vial custom manufacturer.

05.14.24

Breaking News | Collaborations & Alliances | Drug Development

Fulcrum Enters Collaboration & License Agreement with Sanofi

Following positive data from the Phase 3 trial, Fulcrum and Sanofi plan to submit marketing applications for losmapimod.

05.13.24

Biosimilars | Breaking News | Collaborations & Alliances

Boehringer Ingelheim Inks Deal to Expand Patient Access to adalimumab-adbm Injection

Will manufacture its Humira biosimilar for Quallent.

05.13.24

Breaking News | Collaborations & Alliances | Drug Development

AbbVie, Gilgamesh Pharma Partner on Next-Gen Psychiatric Therapies

Will leverage AbbVie's psychiatry expertise and Gilgamesh's research platform to develop neuroplastogens to treat psychiatric disorders.

05.13.24

Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances

Sartorius, Sanofi Partner to Develop End-to-End Platform for Downstream Process Intensification

Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing platform.

05.13.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery

TriLink Invests in New RNA Innovation Center at Johns Hopkins

Will accelerate transformational research in RNA therapeutics and discovery.

05.13.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

Novavax Enters Co-Exclusive Licensing Agreement with Sanofi

Accelerates potential for development of a novel COVID-19-Influenza combination product.

05.10.24

Bio News | Breaking News | Collaborations & Alliances

Ribobay Pharma Integrates Cytvia’s FlexFactory Platform for Oligonucleotides

Will rapidly expand its oligo CRDMO business, producing several hundred kilograms of pharmaceutical oligo per year.

05.10.24

Breaking News | Collaborations & Alliances | Drug Discovery

5 Prime Sciences, Lilly Partner to Advance Cardio-Metabolic Disease Drug Development

Integrates Lilly's cardio-metabolic disease expertise with 5 Prime Sciences' discovery and validation of drug targets.

05.09.24

Breaking News | Collaborations & Alliances | Drug Development

Novo Nordisk, Metaphore Biotechnologies Enter Obesity Therapeutics Research Pact

Aim to develop up to two next-generation therapeutics for obesity management.

05.09.24

Breaking News | Collaborations & Alliances | Drug Development

BioVersys, GSK Expand Strategic TB Collaboration

Aims to accelerate clinical development of alpibectir for the treatment of tuberculosis.

05.07.24

APIs

Collaboration and Partnering on Advanced Manufacturing Technologies

Kevin Webb from the API Innovation Center talks about achieving a domestic supply network for essential/critical medicines.

Online Exclusives CPHI North America 05.06.24

Breaking News | Collaborations & Alliances | Drug Development

GIBF Invests $10M in Nectin Therapeutics

The funds will be used to continue the development of Nectin's portfolio of novel immuno-oncology products.

05.06.24

Breaking News | Collaborations & Alliances | Drug Development

Chiesi and Gossamer Bio Partner to Develop & Commercialize Seralutinib

Aim to expand the seralutinib franchise to reach more patients with pulmonary hypertension worldwide.

05.06.24

Breaking News | Clinical Trials | Collaborations & Alliances

Bespak Enters Collaborations Focused on Advancing the Transition to Low GMP Propellants in pMDIs

Joins forces with The Medicines Evaluation Unit (MEU) and H&T Presspart.

05.03.24

Breaking News | cGMP Manufacture | Collaborations & Alliances

ProPharma & PBL Introduce Cell Factory Box

Enables decentralized manufacturing of all types of Cell & Gene Therapies.

05.02.24

Breaking News | Collaborations & Alliances | Drug Development

Xyphos & Poseida Partner to Develop Convertible CAR-T Programs

Will combine Poseida's proprietary allogeneic CAR-T platform with Xyphos' ACCEL technology.

05.02.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

G1 Therapeutics & Pepper Bio Sign Global Licensing Agreement for Lerociclib

The therapeutic has previously demonstrated efficacy in clinical studies across various cancer types.

05.01.24

Breaking News | Collaborations & Alliances | Drug Development

Bayer, Evotec Partner to Advance Precision Cardiology Therapies 

Aims to identify and validate novel targets leveraging Evotec's disease modelling capabilities using human iPSCs.

04.30.24

Breaking News | Collaborations & Alliances | R&D

Scenic Biotech Enters Research Collaboration with Bristol Myers Squibb

Aims to accelerate the development of BMS’ drug targets by identifying target biology for indication selection and expansion.

04.30.24

Breaking News | Collaborations & Alliances | Drug Discovery

PeptiDream Expands Peptide Discovery Collaboration with Novartis

Will use its Peptide Discovery Platform System technology to identify and optimize novel macrocyclic peptides against targets selected by Novartis.

04.30.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

TriLink to Supply CleanCap Technology to Lonza

Will offer its patented cap analogs for use in Lonza’s global mRNA development and manufacturing services.

04.30.24

Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer

Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies

Will advance the development of Oncotelic’s necroptosis cancer therapy assets.

04.29.24

Breaking News | Collaborations & Alliances | Drug Discovery | Information Technology

MiLaboratories, Miltenyi Biotec Enter Genomics Alliance

Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.

04.29.24

Breaking News | Collaborations & Alliances | Drug Development

BMS, Repertoire Immune Medicines Enter Strategic Autoimmune Vax Pact

Leverages Repertoire's DECODE platform to develop T cell targeted immune medicines.

04.29.24

Breaking News | Collaborations & Alliances | Drug Discovery

Fujifilm & Predictive Oncology Tackle Protein Interference

Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.

04.25.24

Breaking News | cGMP Manufacture | Collaborations & Alliances

Multiply Labs and GenScript Partner to Automate Cell Isolation

Will introduce a fully automated solution for bead-based cell isolation.

04.25.24

Breaking News | Clinical Trials | Collaborations & Alliances | Scale-up/Technology Transfer

FibroBiologics Discusses Opportunities to Work with Charles River

Anticipates a master services agreement for the development and manufacture of FibroBiologics’ fibroblast-based spheroid.

04.25.24

Breaking News | Collaborations & Alliances | Drug Development

BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design

Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.

04.24.24

Breaking News | Collaborations & Alliances

Moderna and OpenAI Join Forces to Transform Healthcare with AI

Moderna is in the process of integrating generative AI responsibly and seamlessly into its operations and capitalizing on next-generation AI innovation.

04.24.24

Breaking News | Clinical Trial Materials | Industry News

Hanmi, Merck Enter Clinical Collaboration & Supply Agreement

To evaluate BH3120 in combination with Merck's KEYTRUDA in progressive or metastatic solid tumors.

04.24.24

Breaking News | Collaborations & Alliances | Drug Development

Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs

Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.

04.24.24

Breaking News | Collaborations & Alliances | Drug Development

Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies

Obtains rights from Washington University to develop and incorporate human HER2 directed antibodies.

04.23.24

Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer

Vertex Obtains Exclusive License to TreeFrog’s C-Stem Technology

Aims to optimize production of its cell therapies for type 1 diabetes.

04.23.24

Breaking News | cGMP Manufacture | Collaborations & Alliances | Scale-up/Technology Transfer

BMS & Cellares Announce Worldwide Capacity Reservation & Supply Agreement

Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.

04.23.24

Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development

BioArctic, Eisai Ink Research Agreement for BAN2802 in AD

To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.

04.22.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research

Aim to discover and develop small molecules for the treatment of rare neurological diseases.

04.22.24

Breaking News | Collaborations & Alliances | Drug Discovery

Takeda and Astellas Agree to Establish Joint Venture Company

New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.

04.22.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines

Aim to address unmet medical needs in infectious diseases.

04.19.24

Breaking News | Collaborations & Alliances | Drug Discovery

Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening Technologies to Customers

Will also co-develop new DELs with an emphasis on novel chemical diversity and drug-likeness to further strengthen their service offering.

04.18.24

Breaking News | cGMP Manufacture | Collaborations & Alliances | Scale-up/Technology Transfer

Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN

Will scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy.

04.18.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec and Variant Bio Partner to Discover & Develop Treatments for Fibrosis

The partnership leverages Variant Bio’s genomic discovery capabilities and VB-Inference platform as well as Evotec’s expertise in antifibrotic drug discovery.

04.18.24

Breaking News | Collaborations & Alliances | Facilities